Current risk estimates based on the A-bomb survivors data - A discussion in terms of the ICRP recommendations on the neutron weighting factor

Radiation Protection Dosimetry

Volumn 126, Issue 1-4, 2007, Pages 423-431

  Rühm, Werner ^a   Walsh, L ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOMIC BOMB SURVIVOR; DOSIMETRY; GAMMA RADIATION; NEUTRON; NEUTRON RADIATION; PRACTICE GUIDELINE; RADIATION ABSORPTION; RADIATION ENERGY; RADIATION PROTECTION; RADIATION SAFETY; RISK ASSESSMENT; ATOMIC BOMB; BODY BURDEN; HUMAN; INTERNATIONAL COOPERATION; JAPAN; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; RADIATION MONITORING; RELATIVE BIOLOGIC EFFECTIVENESS; RISK FACTOR; STATISTICS; SURVIVAL; SURVIVAL RATE; SURVIVOR;

BODY BURDEN; HUMANS; INTERNATIONALITY; JAPAN; NEUTRONS; NUCLEAR WEAPONS; PROPORTIONAL HAZARDS MODELS; RADIATION MONITORING; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVORS;

EID: 42149122882     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncm087     Document Type: Article

References (26)

1. Roesch, W. C. (ed). US-Japan joint reassessment of atomic bomb radiation dosimetry in Hiroshima and Nagasaki-final report, Vols. 1 and 2. Radiation Effects Foundation, Hiroshima, Japan (1987).
2. Thompson, D. E., et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (suppl), 17-67 (1994).
3. Pierce, D. A., Shimizu, Y., Preston, D. L., Vaeth, M. and Mabuchi, K. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer. Radiat. Res. 146, 1-27 (1996).
4. Shimizu, Y., Pierce, D. A., Preston, D. L. and Mabuchi, K. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat. Res. 152, 374-389 (1999).
5. Preston, D. L., Shimizu, Y., Pierce, D. A., Suyama, A. and Mabuchi, K. Studies of Mortality of Atomic Bomb Survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
6. Wolf, C., Lafuma, J., Masse, R., Morin, M. and Kellerer, A. M. Neutron RBE for induction of tumors with high lethality in Sprague-Dawley rats. Radiat. Res. 154, 412-420 (2000).
7. Walsh, L., Rühm, W. and Kellerer, A. M. Cancer risk estimates for gamma-rays with regard to organ-specific doses - Part I: All solid cancers combined. Radiat. Environ. Biophys 43, 145-151 (2004).
8. Kellerer, A. M., Rühm, W. and Walsh, L. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors. Health Phys. 90, 554-564 (2006).
9. Sasaki, M. S., Endo, S., Ejima, Y., Saito, I., Okamura, K., Oka, Y. and Hoshi, M. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons. Radiat. Environ. Biophys., 45, 79-91 (2006).
10. Walsh, L., Rühm, W. and Kellerer, A. M. Cancer risk estimates for gamma-rays with regard to organ-specific doses - Part II: Site-specific solid cancers. Radiat. Environ. Biophys. 43, 225-231 (2004).
11. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (Oxford: Pergamon Press) (1991).
12. R). ICRP Publication 92. Ann. ICRP 33(4) (Oxford: Pergamon Press) (2003).
13. Kellerer, A. M., Leuthold, G., Mares, V. and Schraube, H. Options for the modi.ed radiation weighting factor of neutrons. Radiat. Prot. Dosim. 109, 181-188 (2004).
14. Mares, V. Private communication (2004).
15. Leuthold, G., Mares, V. and Schraube, H. Monte-Carlo calculations of dose equivalents for neutrons in anthropomorphic phantoms using the ICRP 60 recommendations and the stopping power data of ICRU 49. GSF-Report, Neuherberg (2003).
16. Rühm, W., Walsh, L. and Kellerer, A. M. The neutron effective dose to the A-bomb survivors. Technical Report TR221, Radiobiological Institute, Ludwig-Maximilians University Munich (2004).
17. International Commission on Radiation Units and Measurements. Conversion coefficients for use in radiological protection against external radiation. ICRU Report 57 (Bethesda, tMD: ICRU) (1998).
18. Young, R. W. and Kerr, G. D. (eds). Reassessment of the atomic bomb radiation dosimetry for Hiroshima and Nagasaki - Dosimetry System 2002 Report of the Joint US-Japan Working Group. Radiation Effects Foundation, Hiroshima, Japan (2005).
19. Egbert, S. SAIC, Private Communication (2005).
20. Kellerer, A. M., Rühm, W. and Walsh, L. Accounting for radiation quality in the analysis of the solid cancer mortality among A-bomb survivors. Technical Report TR223, Radiobiological Institute, Ludwig-Maximilians University Munich (2004).
21. Kellerer, A. M. and Walsh, L. Risk estimation for fast neutrons with regard to solid cancer. Radiat. Res. 156, 708-717 (2001).
22. Preston, D. L., Pierce, D. A., Shimizu, Y., Cullings, H.M., Fujita, S., Funamoto, S. and Kodama, K. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
23. Stram, D. O., Sposto, R., Preston, D., Abrahamson, S., Honda, T. and Awa, A.A. Stable chromosome aberrations among A-bomb survivors: An update. Radiat. Res. 136, 29-36 (1993).
24. Kodama, Y., Pawel, D., Nakamura, N., Preston, D., Honda, T., Itoh, M., Nakano, M., Ohtaki, K., Funamoto, S. and Awa, A. A. Stable chromosome aberrations in atomic bomb survivors: Results from 25 years of investigation. Radiat. Res. 156, 337-346 (2001).
25. Rühm, W., Walsh, L. and Chomentowski, M. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki. Radiat. Environ. Biophys. 42, 119-128 (2003).
26. Preston, D. DS86 gamma and neutron colon dose estimates for LSS survivors by distance. RERF Update 9(1), (1998).